39.83MMarket Cap-9122P/E (TTM)
5.125High4.470Low14.23KVolume4.815Open4.940Pre Close66.37KTurnover0.25%Turnover RatioLossP/E (Static)8.91MShares5.59052wk High1.51P/B25.89MFloat Cap3.34052wk Low--Dividend TTM5.79MShs Float13.200Historical High--Div YieldTTM13.27%Amplitude1.000Historical Low4.663Avg Price1Lot Size
ImmuCell Stock Forum
ImmuCell Corporation (Nasdaq: ICCC), a key player in the animal health industry, has recently announced its preliminary, unaudited sales results for the first quarter of 2024, and the figures are nothing short of impressive. With a staggering 111% increase in sales compared to the same period in 2023, and a 42% increase from the last quarter of ...
No comment yet